Ignite Creation Date:
2024-05-05 @ 4:41 PM
Last Modification Date:
2024-10-26 @ 9:22 AM
Study NCT ID:
NCT00290771
Status:
TERMINATED
Last Update Posted:
2011-05-16
First Post:
2006-02-10
Brief Title:
Efficacy and Safety of Imatinib Mesylate Plus Hydroxyurea HU in Patients With Recurrent Glioblastoma Multiforme GBM
Sponsor:
Novartis
Organization:
Novartis